Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,945 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dynamics of Liver Stiffness Measurement and Clinical Course of Primary Biliary Cholangitis.
Lam L, Soret PA, Lemoinne S, Hansen B, Hirschfield G, Gulamhusein A, Montano-Loza AJ, Lytvyak E, Parés A, Olivas I, Londono MC, Rodríguez-Tajes S, Eaton JE, Osman KT, Schramm C, Sebode M, Lohse AW, Dalekos G, Gatselis N, Nevens F, Cazzagon N, Zago A, Russo FP, Floreani A, Abbas N, Trivedi P, Thorburn D, Saffioti F, Barkai L, Roccarina D, Calvaruso V, Fichera A, Delamarre A, Sobenko N, Villamil AM, Medina-Morales E, Bonder A, Patwardhan V, Rigamonti C, Carbone M, Invernizzi P, Cristoferi L, van der Meer A, de Veer R, Zigmond E, Yehezkel E, Kremer AE, Deibel A, Bruns T, Große K, Wetten A, Dyson JK, Jones D, Levy C, Tanaka A, Dumortier J, Pageaux GP, de Lédinghen V, Carrat F, Chazouillères O, Corpechot C; Global & ERN Rare-Liver PBC Study Groups. Lam L, et al. Among authors: hansen b. Clin Gastroenterol Hepatol. 2024 Dec;22(12):2432-2441.e2. doi: 10.1016/j.cgh.2024.06.035. Epub 2024 Jul 15. Clin Gastroenterol Hepatol. 2024. PMID: 39019421 Free article.
Retreatment of hepatitis C non-responsive to interferon. A placebo controlled randomized trial of ribavirin monotherapy versus combination therapy with Ribavirin and Interferon in 121 patients in the Benelux [ISRCTN53821378].
Veldt BJ, Brouwer JT, Adler M, Nevens F, Michielsen P, Delwaide J, Hansen BE, Schalm SW; Benelux Study Group on Treatment of Chronic Hepatitis C. Veldt BJ, et al. BMC Gastroenterol. 2003 Aug 29;3:24. doi: 10.1186/1471-230X-3-24. BMC Gastroenterol. 2003. PMID: 12948399 Free PMC article. Clinical Trial.
Reduction of relapse rates by 18-month treatment in chronic hepatitis C. A Benelux randomized trial in 300 patients.
Brouwer JT, Nevens F, Bekkering FC, Bourgeois N, Van Vlierberghe H, Weegink CJ, Lefebvre V, Van Hattum J, Henrion J, Delwaide J, Hansen BE, Schalm SW; Benelux Study Group On Treatment Of Chronic Hepatitis C. Brouwer JT, et al. J Hepatol. 2004 Apr;40(4):689-95. doi: 10.1016/j.jhep.2003.12.017. J Hepatol. 2004. PMID: 15030987 Clinical Trial.
Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid.
Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, Houben MH, Witteman BJ, van Erpecum KJ, van Buuren HR; Dutch PBC Study Group. Kuiper EM, et al. Among authors: hansen be. Gastroenterology. 2009 Apr;136(4):1281-7. doi: 10.1053/j.gastro.2009.01.003. Epub 2009 Jan 14. Gastroenterology. 2009. PMID: 19208346
The long-term effect of ursodeoxycholic acid on laboratory liver parameters in biochemically non-advanced primary biliary cirrhosis.
Kuiper EM, Hansen BE, Lesterhuis W, Robijn RJ, Thijs JC, Engels LG, Koek GH, Aparicio MN, Kerbert-Dreteler MJ, van Buuren HR; Dutch PBC study group. Kuiper EM, et al. Among authors: hansen be. Clin Res Hepatol Gastroenterol. 2011 Jan;35(1):29-33. doi: 10.1016/j.gcb.2010.07.018. Clin Res Hepatol Gastroenterol. 2011. PMID: 20810227
2,945 results